Will Grove Collaborative Make it Over the Goal Line?

by | Jun 2, 2022

The Branson-backed sustainable consumer goods company reports soft Q1 results ahead of 6.14 merger vote

————————————————-
Free Investor Resources from Boardroom Alpha
—————————————————-
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

Grove Collaborative Announces Q1 Earnings Results

Grove Collaborative announced disappointing Q1 earnings results, with revenues and margins showing sequential and YoY declines. The sustainable consumer goods company has a DA with Richard Branson-backed Virgin Group Acquisition Corp. II (VGII). Grove’s Q1 revenue of $90.5 million declined 11% year-over-year. EBITDA margin deteriorated considerably — (43.8)% versus (30.7)% in the first quarter of 2021Q4 2021.

The company issued revised 2022, 2033 and 2024 guidance. Notably, 2022 revenue guidance calls for a YoY revenue decline of 21% at the midpoint (Grove’s 2021 revenues were $383.7 million).

  • 2022E – Net revenue of $300 to $310 million; adjusted EBITDA margin of -29% to -32%
  • 2023E – Net revenue of $300 to $310 million; adjusted EBITDA margin of -13% to -16%
  • 2024E – Net revenue of $330 to $360 million; adjusted EBITDA margin of greater than 0%

Despite bold plans to launch multiple sustainable brands spanning the personal care, paper and beauty categories, Grove laid off approximately 17% of its workforce in March. The transaction, which is expected to close in Q2, values Grove at $1.5 billion. Merger vote is coming up on 6.14. VGI already announced a $50M backstop back in April.

BSGA Extends Deadline

Blue Safari Group Acquisition Corp. (BSGA) uses first of 2 extensions, adding $0.10 and extending until September 14, 2022. The SPAC has a DA with crypto mining datacenter provider Bitdeer.

Boardroom Alpha SPAC Market Review for May

Time is running out as SPACs scramble to finance deals at almost any cost. Expect more deSPAC duds as sponsors push low-quality companies at onerous valuations — for the simple purpose of protecting at-risk capital. Full report here.

SPAC Calendar

Source: Boardroom Alpha

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

<a href="https://www.boardroomalpha.com/author/joanna/" target="_self">Joanna Makris</a>

Joanna Makris

Joanna has been analyzing and investing in emerging technologies for over two decades, having led the Technology, Media, and Telecom research at several global investment banks, including Mizuho Securities and Canaccord Genuity. Navigating stock market volatility since it all began in 2000. Banjo player, artist, and frittata-maker.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – May 2022

Inflation, rising interest rates, and reduced corporate earnings across the board have led to persistent market gyrations which prove its too early for bottom fishing. The stampede out of deSPACs now makes it ‘deal-or-die’ time for those without targets.

SPAC Market Review – April 2022

The market is a mess right now. A hawkish Fed and even more cautious SEC are slowing deals….but may raise the bar for more quality SPACs down the line.

SPAC Market Review – March 2022

Despite increased scrutiny and apparent investor fatigue, deals are getting done and SPACs remain an attractive path to the public markets.

SPAC Research & Analysis

SPAC Daily: AMAO Strikes Royalty Management Deal

AMAO, with just $16M left, announced a post close business DA. Podcast: Know Who Drives ReturnDaily SPAC NewsletterFull SPAC Listing American Acquisition Opportunity Inc. (AMAO) provided some late afternoon fireworks in announcing a $111M EV SPAC deal for Royalty...

Alvotech Puts Iceland on the SPAC Map

Icelandic biopharma Alvotech deSPACs today. DHAC announces DA with VSee Lab. Deal termination for AKIC and visual effects company DNEG. A flurry of extension votes. And the rest of the day’s news in SPACs.

Know Who Drives Return Podcast

NYC Pension Funds Want Amazon Accountable for Human Capital

AMZN stock is performing, but are warehouse workers paying the price? We talk to Assistant NYC Comptroller Michael Garland on the NYC Pension Funds’ move to unseat two Amazon board members responsible for human capital management at the tech giant.

Boardroom Alpha Daily Read

Board blow-up at Redbox Entertainment. Mill Road Capital Pushing for a Sale of Big Lots. Happy Earth Day! A perfect time to tune into our latest ESG podcast.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.